[Editorial] Eliminating cervical cancer
2020 promises to be a landmark year for cervical cancer and, with World Cancer Day on Feb 4, it is an apt time to reflect on the prospect of elimination. WHO has a highly ambitious plan for elimination: 90% of girls fully vaccinated by age 15 years, 70% of women ...
Прочесть полный текст публикации и оставить комментарий могут только зарегистрированные пользователи.
[Editorial] Lung cancer: some progress, but still a lot more to do
In a report, State of Lung Cancer, released on Nov 12, the American Lung Association shows that 5-year survival for US patients with lung cancer has improved from a dismal 17·2% 10 years ago, to 21·7% now. This improvement is attributed to a combination of personalised, biomarker-driven treatment ...
Прочесть полный текст публикации и оставить комментарий могут только зарегистрированные пользователи.
[Series] Changing the landscape for type 1 diabetes: the first step to prevention
Over several decades, studies have described the progression of autoimmune diabetes, from the first appearance of autoantibodies until, and after, the diagnosis of clinical disease with hyperglycaemia and insulin dependence. Despite the improved management of type 1 diabetes with exogenous insulin, most patients do not meet clinical glycaemic goals, and ...
Прочесть полный текст публикации и оставить комментарий могут только зарегистрированные пользователи.
[Series] Advances in β-cell replacement therapy for the treatment of type 1 diabetes
The main goal of treatment for type 1 diabetes is to control glycaemia with insulin therapy to reduce disease complications. For some patients, technological approaches to insulin delivery are inadequate, and allogeneic islet transplantation is a safe alternative for those patients who have had severe hypoglycaemia complicated by impaired hypoglycaemia ...
Прочесть полный текст публикации и оставить комментарий могут только зарегистрированные пользователи.
[Series] Advances in technology for management of type 1 diabetes
Technological advances have had a major effect on the management of type 1 diabetes. In addition to blood glucose meters, devices used by people with type 1 diabetes include insulin pumps, continuous glucose monitors, and, most recently, systems that combine both a pump and a monitor for algorithm-driven automation of ...
Прочесть полный текст публикации и оставить комментарий могут только зарегистрированные пользователи.
